FY2025 EPS Estimates for TerrAscend Cut by Atb Cap Markets

TerrAscend Corp. (OTCMKTS:TSNDF) – Investment analysts at Atb Cap Markets reduced their FY2025 earnings estimates for shares of TerrAscend in a note issued to investors on Monday, December 9th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings per share of ($0.13) for the year, down from their previous forecast of ($0.09). Atb Cap Markets currently has a “Hold” rating on the stock. The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share.

TerrAscend Stock Performance

TerrAscend stock opened at $0.68 on Wednesday. The company has a current ratio of 1.35, a quick ratio of 0.69 and a debt-to-equity ratio of 0.81. The firm’s 50 day moving average price is $0.96 and its 200-day moving average price is $1.21. TerrAscend has a 1 year low of $0.62 and a 1 year high of $2.45.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.